• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

RecommendedBeta
Recent
Webcasts
Press releases

Latest research

Trending

Upcoming webcasts

Inderes illustration

Connecting investors and companies

Inderes is a hub connecting investors and listed companies. We are home to over 70 000 investors and 400 Nordic listed companies. Log in to keep up with your favourite companies!

Create an accountLog in
 
OMXHPI+0.71 %
OMXH25+0.61 %
OMXSPI-0.47 %
SITOWS+7.42 %
MERUS+6.07 %
WITTED+4.64 %
NANOFH-6.25 %
HEALTH-6.28 %
HRTIS-12.14 %
 
 

Past

Clas Ohl
Clas Ohl
 
Remedy will release Control Resonant in late September
Analyst Comment9 hours ago by
Roni Peuranheimo

Remedy will release Control Resonant in late September

The game is by far the most critical driver of the investment case and earnings trend.

Remedy Entertainment
Herantis: Clarity on efficacy study details
Research7 hours ago by
Antti Siltanen

Herantis: Clarity on efficacy study details

The study will produce high-quality data on the safety of the Parkinson's disease drug candidate and preliminary data on its efficacy.

Herantis Pharma
Articleyesterday by
Marianne Palmu

Where is my momentum?

Momentum investing has once again captured investors' interest, thanks to the AI boom. The strategy is based on a simple observation: shares that have performed well in the recent past often continue their strong development in the medium term.

Join Inderes community

Research, tools and community to support better investment decisions.

FREE account
The market's most popular morning review
Analysts' recommendations and comments
Stock comparison and the investor discussion forum
PREMIUM account
All company reports and analyses
Premium content: model portfolio, insider transactions, Premium articles
Inderes MCP: Inderes data directly into your AI tools
Create account
Solar Foods: First Solein consumer product for sale in the United States
Analyst Comment8 hours ago by
Thomas Westerholm

Solar Foods: First Solein consumer product for sale in the United States

The first consumer product containing Solein has been launched in the United States, in collaboration with Ambrosia Collective.

Solar Foods
Articleyesterday by
Marianne Palmu

Eurozone inflation: Still trying to climb

Eurozone inflation accelerated to 3.2% in May from 3.0% in April, as energy costs and service prices rose sharply. The figure published by Eurostat on Tuesday reinforces expectations of an interest rate hike by the European Central Bank later this month.

Framery Initiation of Coverage: Soundproof value creation
Extensive research5/28/2026, 9:34 AM by
Thomas Westerholm

Framery Initiation of Coverage: Soundproof value creation

Framery is the global market leader in soundproofed office pods, which are a growing category and which the company has been instrumental in shaping.

Framery Group
Article5/31/2026, 10:38 AM by
Marianne Palmu

Watch out for an inflation jump (short or long)

Last week was a mixed one for the European and US stock markets. Nasdaq Helsinki declined for a change, but the US markets again targeted new highs. Two themes continue to recur in the markets: the effects of the Middle East conflict and the momentum of AI stocks. The price of oil decreased by 18% in May, which has been reflected in the market. In many AI stocks, nervousness seems to have turned into a hybrid loan.

CapMan extensive report: Scale-up time
Extensive research5/29/2026, 5:36 AM by
Sauli Vilén

CapMan extensive report: Scale-up time

CapMan is currently in the midst of the largest fundraising cycle in its history, and the success of this effort will largely determine the stock’s trajectory in the coming years. If the fundraising is successful, the share valuation is favorable.

CapMan
Bioretec seeks additional savings through change negotiations
Analyst Commentyesterday by
Antti Siltanen

Bioretec seeks additional savings through change negotiations

The company is seeking additional savings of 0.2 MEUR, as production capacity is still too high relative to demand.

Bioretec
KPY osk, Yhtiötilaisuus
Webcastyesterday

KPY osk, Yhtiötilaisuus

KPY
Metacon: 144 MSEK capital raise secures financing but adds dilution
Analyst Comment10 hours ago by
Lucas Mattsson

Metacon: 144 MSEK capital raise secures financing but adds dilution

In our view, the raise lowers short-term financing risks by securing working capital needs for ongoing customer projects and enabling the repayment of temporary project financing.

Metacon
North Media (Investment Case): Improved Q1 profit, but lowered guidance ceiling
Research6 hours ago by
Jacob Frehr, Rasmus Køjborg

North Media (Investment Case): Improved Q1 profit, but lowered guidance ceiling

Today, we publish our updated North Media A/S investment case following the Q1 2026 report. North Media delivered improved Q1 profitability with EBIT rising to DKK 4m and EBITDA up 72%, though management cut the top end of 2026 guidance on a weak start in SDR and BoligPortal. The stock continues to trade at a significant discount to peers, as the large securities portfolio results in a very low implied EV, leaving the operating business valued at close to zero.

North Media
Herantis Pharma, webcast, Update on Phase 2 preparation
Webcastyesterday

Herantis Pharma, webcast, Update on Phase 2 preparation

Herantis Pharma
Article5/27/2026, 4:43 PM by
Marianne Palmu

Warsh and Bessent are now facing the same problems

Donald Trump's second term has entered a new phase, where responsibility for the economy rests even more firmly on the administration's shoulders. Trump’s nominee became the head of the Federal Reserve, so it is even harder to find a scapegoat for monetary policy. Economic policy, meanwhile, faces the same problems as the central bank.

Article5/27/2026, 4:07 AM by
Marianne Palmu

EU giants want more trade restrictions against China

France, Italy, Spain, and two smaller EU countries (the Netherlands and Lithuania) are pressuring the Union to improve trade restrictions to better compete against China and protect their own industries.

Regulatory press release5/28/2026, 6:25 AM

Sotkamo Silver AB: Insiderinformation, positive profit warning. High silver price increases profitability.

Sotkamo Silver
Article5/26/2026, 4:30 AM by
Marianne Palmu

China's industrial leap extends and takes market share from others

China is currently in the midst of the most significant economic revision in its history. The country, which for decades served as an assembly point for cheap mass production and foreign technology, is rapidly moving towards an era that the Beijing administration calls "new viable productive forces."

Curasight (Investment Case): Four high-value read-outs on track for H2 2026
Researchyesterday by
Michael Friis, Victor Skriver

Curasight (Investment Case): Four high-value read-outs on track for H2 2026

In connection with Curasight's Q1 2026 interim report, we have updated our Investment Case. Our investment case covers the key investment reasons, risks, and valuation perspectives.

Curasight
Easor Q1'26: Smooth start to independently listed status
Research5/22/2026, 7:19 AM by
Atte Riikola

Easor Q1'26: Smooth start to independently listed status

The stock is trading near the lower end of our estimated fair value range (EUR 0.7-1.5).

Easor
Regulatory press release5/13/2026, 10:00 AM

Inside information, profit warning: Koskisen Corporation lowers its profit guidance for 2026 regarding the adjusted EBITDA margin and publishes preliminary key figures regarding the first quarter of 2026

Koskisen

Latest research

Herantis: Clarity on efficacy study details
Reduce
Herantis Pharma
03.06.2026
CapMan extensive report: Scale-up time
Accumulate
CapMan
29.05.2026
Framery Initiation of Coverage: Soundproof value creation
Accumulate
Framery Group
28.05.2026
Verve Q1'26: First steps on campaign to rebuild trust
Accumulate
Verve Group
28.05.2026
Multitude Q1'26: New pieces to the growth platform
Buy
Multitude
22.05.2026
View all

Trending

CapMan extensive report: Scale-up time
29.05.2026 Extensive research
Borgestad ASA: Mandatory notification of trade
20.06.2025 Regulatory press release
Orion: ODM-212-aihiosta ensimmäisiä tuloksia
01.06.2026 Analyst Comment
Framery Initiation of Coverage: Soundproof value creation
28.05.2026 Extensive research
Case: Asiantuntijayhtiöiden henkilöstökatteet jatkaneet heikentymistä
28.05.2026 Analyst Comment

Upcoming webcasts

Life Science Night | November 30, 2026
30.11.2026 klo 16.00 Aiforia Technologies
Show all